Squeezed on all sides -- including from raw material costs (which are at unprecedented highs), narrowing access to feedstocks, and growing competition in commodity markets -- chemical firms must create new high-value materials and services to survive and profit. This report summarizes the second annual CHF-SCI Innovation Day and suggests solutions for current challenges based on this forum in which scientists and technology managers gather to explore frontier areas for the chemical industry. The industry¿s future, the authors argue, lies in a strategic ¿wager¿ on disruptive technologies, balanced by incremental steps to develop new feedstocks and manufacturing processes that yield novel materials with less environmental impact.

Competition is becoming ever fiercer in the chemical industry as new firms from such emerging economies as China and India enter the market and as technological advances, potential new regulations, and rising energy and feedstock costs shrink profit margins. Yet chemical firms are also discovering that cooperation, even between competitors, is necessary for meeting today¿s challenges. Today¿s market dilemmas and innovation systems are too complex for any one org. Successful networks must include competitors working in partnership. This report describes a variety of partnerships among chemical and materials firms that combine cooperation and competition in novel, forward-looking ways.

The neuro rehab text that mirrors how you learn and how you practice! Take an evidence-based approach to the neurorehabilitation of adult and pediatric patients across the lifespan that reflects the APTA’s patient management model and the WHO’s International Classification of Function (ICF). You’ll study examination and interventions from the body structure/function impairments and functional activity limitations commonly encountered in patients with neurologic disorders. Then, understanding the disablement process, you’ll be able to organize the clinical data that leads to therapeutic interventions for specific underlying impairments and functional activity limitations that can then be applied as appropriate anytime they are detected, regardless of the medical diagnosis.